Remifentanil Hydrochloride Patent Expiration
Remifentanil Hydrochloride was first introduced by Mylan Institutional Llc
Remifentanil Hydrochloride Patents
Given below is the list of patents protecting Remifentanil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ultiva |
US5866591 (Pediatric) | Stable formulations of remifentanil |
Mar 10, 2018
(Expired) | Mylan Institutional |
| Ultiva | US5866591 | Stable formulations of remifentanil |
Sep 10, 2017
(Expired) | Mylan Institutional |
Remifentanil Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List